ProShare Advisors’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.16M Buy
30,597
+5,868
+24% +$317K ﹤0.01% 685
2026
Q1
$1.29M Sell
24,729
-5,920
-19% -$355K ﹤0.01% 745
2025
Q4
$1.8M Buy
30,649
+1,789
+6% +$109K ﹤0.01% 706
2025
Q3
$1.61M Buy
28,860
+929
+3% +$49.8K ﹤0.01% 721
2025
Q2
$1.44M Buy
27,931
+2,866
+11% +$144K ﹤0.01% 724
2025
Q1
$1.47M Buy
25,065
+1,015
+4% +$68.8K ﹤0.01% 720
2024
Q4
$1.73M Buy
24,050
+2,559
+12% +$188K ﹤0.01% 732
2024
Q3
$1.72M Sell
21,491
-1,679
-7% -$126K ﹤0.01% 694
2024
Q2
$1.66M Sell
23,170
-2,229
-9% -$164K ﹤0.01% 689
2024
Q1
$1.79M Sell
25,399
-762
-3% -$54.5K ﹤0.01% 681
2023
Q4
$2.02M Sell
26,161
-2,045
-7% -$135K 0.01% 651
2023
Q3
$1.92M Sell
28,206
-1,318
-4% -$104K 0.01% 651
2023
Q2
$2.41M Sell
29,524
-143
-0.5% -$11.5K 0.01% 634
2023
Q1
$2.2M Buy
29,667
+8,420
+40% +$649K 0.01% 645
2022
Q4
$1.76M Sell
21,247
-73
-0.3% -$5.8K 0.01% 640
2022
Q3
$1.51M Sell
21,320
-2,468
-10% -$213K 0.01% 663
2022
Q2
$2.06M Sell
23,788
-9,428
-28% -$884K 0.01% 643
2022
Q1
$3.6M Sell
33,216
-924
-3% -$95.3K 0.01% 615
2021
Q4
$4.42M Buy
34,140
+7,944
+30% +$974K 0.01% 596
2021
Q3
$3.17M Buy
26,196
+8,828
+51% +$1.07M 0.01% 611
2021
Q2
$1.96M Buy
17,368
+2,512
+17% +$264K 0.01% 729
2021
Q1
$1.42M Sell
14,856
-12
-0.1% -$1.09K ﹤0.01% 819
2020
Q4
$1.18M Sell
14,868
-23,044
-61% -$1.67M ﹤0.01% 808
2020
Q3
$2.35M Buy
37,912
+908
+2% +$59.1K 0.01% 537
2020
Q2
$2.44M Buy
37,004
+7,612
+26% +$456K 0.01% 523
2020
Q1
$1.39M Sell
29,392
-20,136
-41% -$1.01M 0.01% 538
2019
Q4
$2.72M Sell
49,528
-6,684
-12% -$351K 0.01% 554
2019
Q3
$2.75M Sell
56,212
-3,708
-6% -$186K 0.02% 527
2019
Q2
$3.12M Sell
59,920
-9,944
-14% -$501K 0.02% 498
2019
Q1
$3.47M Buy
69,864
+4,200
+6% +$189K 0.02% 484
2018
Q4
$2.38M Sell
65,664
-13,672
-17% -$571K 0.02% 538
2018
Q3
$4.05M Sell
79,336
-204
-0.3% -$9.04K 0.03% 465
2018
Q2
$2.94M Sell
79,540
-6,264
-7% -$239K 0.02% 542
2018
Q1
$3.24M Sell
85,804
-11,908
-12% -$421K 0.02% 521
2017
Q4
$3.17M Buy
97,712
+524
+0.5% +$16.6K 0.02% 517
2017
Q3
$2.94M Buy
97,188
+7,080
+8% +$210K 0.03% 483
2017
Q2
$2.65M Sell
90,108
-5,084
-5% -$139K 0.03% 496
2017
Q1
$2.42M Sell
95,192
-19,876
-17% -$513K 0.03% 506
2016
Q4
$2.96M Buy
115,068
+5,284
+5% +$139K 0.03% 450
2016
Q3
$3M Sell
109,784
-18,276
-14% -$502K 0.04% 370
2016
Q2
$3.61M Buy
128,060
+580
+0.5% +$14.9K 0.05% 309
2016
Q1
$3.01M Sell
127,480
-11,432
-8% -$252K 0.04% 340
2015
Q4
$3.13M Buy
138,912
+8,084
+6% +$184K 0.04% 385
2015
Q3
$3.02M Sell
130,828
-14,716
-10% -$369K 0.04% 368
2015
Q2
$3.58M Sell
145,544
-1,792
-1% -$44.7K 0.05% 344
2015
Q1
$3.69M Buy
147,336
+18,060
+14% +$429K 0.04% 383
2014
Q4
$2.99M Sell
129,276
-27,140
-17% -$621K 0.03% 456
2014
Q3
$3.66M Buy
156,416
+1,628
+1% +$38.2K 0.05% 397
2014
Q2
$3.58M Buy
154,788
+24,176
+19% +$534K 0.05% 415
2014
Q1
$2.79M Sell
130,612
-33,108
-20% -$745K 0.03% 554
2013
Q4
$3.88M Buy
163,720
+96,748
+144% +$2.1M 0.06% 405
2013
Q3
$1.34M Buy
66,972
+27,800
+71% +$528K 0.03% 649
2013
Q2
$677K Buy
+39,172
New +$650K 0.01% 1096

Other funds holding TECH

ProShare Advisors's TECH Position: Q2 2026 in Review

ProShare Advisors increased its Bio-Techne (TECH) stake by 24% in Q2 2026, buying an estimated $317K and bringing the position to 30,597 shares worth $2.16M. The position accounts for ﹤0.01% of the portfolio, ranked #685.

ProShare Advisors first reported a position in TECH in Q2 2013 and has held it in 53 quarters since. The position peaked at $4.42M in Q4 2021. 595 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • ProShare Advisors held 30,597 shares of Bio-Techne worth $2.16M as of Q2 2026.
  • ProShare Advisors bought 5,868 Bio-Techne shares in Q2 2026, an estimated $317K.
  • Bio-Techne made up ﹤0.01% of ProShare Advisors's portfolio in Q2 2026, its #685 holding.
  • ProShare Advisors first reported a position in Bio-Techne in Q2 2013 and has held it in 53 quarters since.
  • ProShare Advisors's Bio-Techne position peaked at $4.42M in Q4 2021.
  • 595 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on ProShare Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.